Bank of Nova Scotia
EGRX

Bank of Nova Scotia’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bank of Nova Scotia’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-85,293
Closed -$2.49M – 1208
2022
Q4 		$2.49M Buy
+85,293
New +$2.49M 0.01% 598